DYEE Capital

Degron Therapeutics is a drug discovery platform. They provide the discovery and development of a new class of targeted protein degradation therapeutics and small molecule molecular glue degrader drugs. Degron Therapies aspires to be a global leader in the discovery and development of small molecule molecular glue degrader (MGD) medicines, a new class of targeted protein degradation therapeutics. Degron has assembled a team of world-class executives and scientific leaders to apply its scientific expertise to the identification and validation of disease targets, particularly those that are inaccessible to conventional small molecule inhibitors, as well as novel selective MGD compounds to address unmet medical needs across all therapeutic areas.

Microclear is the developer and manufacturer of medical instruments intended to enhance ophthalmology and optometry imaging services. They provide high-quality Chinese-made equipment and services to hospitals and basic medical institutes all around the world. They offer a confocal retinal ophthalmoscope, a handheld fundus camera, a handheld slit lamp, and a vision screener.

Cloudbreak Therapeutics is a clinical-stage biotechnology company focusing on ocular drug development. Cloudbreak Therapeutics operates a capital efficient business model based upon VIC + 505b(2). We repurpose approved systemic drugs for ocular delivery to treat eye diseases and quickly advance drug candidates to complete proof-of-concept (POC) Phase II clinical trials and to out-license global rights for Phase III clinical trials, product registration, and commercialization. Fully embracing the pharmaceutical development ecosystem, we utilize contract research organizations (CRO) for non-clinical, CMC and clinical development to efficiently maximize capital for drug development.

GenFleet Therapeutics is a developer and researcher of molecular pharmaceuticals targeting cancer treatments. The company specializes in developing innovative molecular-level pharmaceuticals and antibody drugs targeting various cancer systems, providing effective medical solutions to reactivate tumor-specific immune responses and to mobilize the body's own immune system.

Innogen Pharmaceutical Technology is a high-tech, innovation-driven international pharmaceutical manufacturing, and R&D company.

Zhimeng is also actively developing novel small molecule drugs to treat neurological diseases, such as epilepsy, pains and strokes.

SinoTau is a total solution provider specializing in generic drugs and innovative drugs. They provide cardiovascular fields, neurodegeneration fields, and tumor fields. The company specializes in the early development of antibody biopharmaceuticals and is researching a variety of medicines for use in treating cancers, neurological illnesses, and autoimmune diseases.

Leads Biolabs is a biotechnology company that develops treatment outcomes and access for patients worldwide. The company is committed to researching and developing novel antibody-based therapeutics in oncology and immunological disease areas in order to meet patients' global unmet needs. On the monoclonal antibody and bispecific antibody development technology platform, they already have a robust research and development pipeline with over ten innovative cancer immunotherapy antibody projects. Leads Biolabs was founded in 2014 and is headquartered in China.

Ionova Life Science is an anti-tumor drug developer dedicated to the development of innovative types of tumor-targeted drugs and tumor immunomodulatory drugs, including oncology, immuno-oncology, and cardiac metabolic diseases. Force contact

Phanes Therapeutics is a biotech company focused on discovery and development of therapeutics for solid tumors and eye diseases. Their extensive experience and deep scientific knowledge strongly position us to discover and advance robust therapeutic molecules. Through scientific innovation, we deliver better treatment options for patients. Their mission is to relentlessly seek scientific and technological solutions to improve the lives of patients globally.

Innogen Pharmaceutical Technology is a high-tech, innovation-driven international pharmaceutical manufacturing, and R&D company.

Sceneray Co. Ltd, located at Singapore Industrial Park in Suzhou China, is a medical device company dedicated to the design, development, and distribution of neuromodulation devices. The core team of Sceneray is made up by experts with deep China and overseas experiences in neuromodulation device development, manufacturing, and marketing. Sceneray holds many patents and keeps on exploring the frontiers in neuromodulation. Being an international high-tech medical and competitive company, Sceneray is dedicated to providing patients with high-quality and efficacious treatments.

FutureGen is a biopharmaceutical company that develops innovative biologics. The company works in the fields of immunology and cancer, concentrating on the creation and commercialization of novel biologics. The STEP (Structure-based Targeted Evolution Platform) from FutureGen is a cutting-edge screening platform designed specifically for protein drug screening. It integrates several technologies to quickly screen and produce the best antibodies. FutureGen has experience in medication development, clinical research, CMC, and quality in the business world.

Ark Biosciences is a biopharmaceutical company that is dedicated to the discovery and development of innovative therapeutics to address unmet medical need, especially in the area of respiratory viral infection and viral hepatitis, for global and China market. We strive to build a science-driven biopharmaceutical company that aims to be a leader in antiviral drug discovery and development. To achieve so, we aspire for the excellence of science and be innovative. We operate with a razor-sharp focus and aggressiveness with a timely and cost efficient manner. We create a healthy and rewarding work environment for employees, and seek a superior rate of return for investors and partners.

InventisBio is a biotech company whose product pipeline includes small molecule drug candidates for targeted therapies in lung cancer, breast cancer and gout. The company is also actively developing drugs that can be combined with other immune-oncology targeted therapies, such as PD-1 antibody, for various cancer indications. The company is co-founded by Dr. Yaolin Wang and other scientists who have previously worked at Merck and Schering-Plough, leading various drug discovery projects in oncology, metabolic and infectious disease areas.

LP Pharmaceuticals (Xiamen) Co., Ltd., located in Xiamen Biomedical Industry Base which formulates and manufactures pharmaceuticals with enhanced delivery properties. The company was founded in 2012 by a group of scientists and business professionals with extensive experience in the US and Chinese pharmaceutical industry. Proprietary delivery platforms include mucosal and oral controlled release. Therapeutic areas currently concern central nervous system, digestive system, cardiovascular, cancer and AIDS.

Ionova Life Science is an anti-tumor drug developer dedicated to the development of innovative types of tumor-targeted drugs and tumor immunomodulatory drugs, including oncology, immuno-oncology, and cardiac metabolic diseases. Force contact

A1Food is a food and snacks brand which mainly sells nuts and pastry. Its products offered includes nut set, nut seaweed, oxcake, and blasting liquid crisp. A1Food food sells its product online. The company was founded in 2018 and is headquartered in Xiamen, Fujian.

Allist Pharmaceuticals is a pharmaceutical enterprise that discovers, develops, and commercializes innovative medicines. Allist Pharmaceuticals is oriented by unmet clinical demands in the global pharmaceutical market, with a special focus on tumor treatment, under the development concept of advancing long life through scientific and technological innovation. Allist Pharmaceuticals develops medicines with the commitment to creating safe, effective, and inclusive innovative drugs with independent intellectual property rights.

Hebaodan is a S2B2C e-commerce platform.

ZongMu Technology was founded in January 2013. Headquartered in Pudong ZhangJiang high-tech park of Shanghai, ZongMu has RD centers in Beijing and ShenZhen respectively. Through its innovative solution and excellent service to the local market, ZongMu has shipped multiple SurroundView ADAS (Advanced Driving Assistance System) in main stream OEM automotive markets, becoming the leading SurroundView ADAS solution vendor for China domestic market and formed strategic partnership with multiple OEM car makers and their tier1 suppliers.

Weijiecheng is a third-party city-based logistics service provider, providing the distribution of catering, retail, fresh e-commerce, fast-moving consumer goods and other consumer logistics markets with the “consultation + logistics service” model. Shanghai Kexin Logistics Co., Ltd. is a service brand.

Fawang Logistics is an domestic enterprise specializing in e-commerce warehouse logistics services, and has now developed into a leading domestic third-party logistics service enterprise. Relying on the national warehousing network, FANET Logistics deeply integrates distribution resources, combined with self-developed logistics systems and intelligent hardware to provide enterprises with all-channel logistics services.

Borns Robot is a Chongqing-based minimally invasive surgical robot maker, providing digital diagnosis and treatment solutions for doctors and patients.

KTVme is a digital entertainment platform.

A1Food is a food and snacks brand which mainly sells nuts and pastry. Its products offered includes nut set, nut seaweed, oxcake, and blasting liquid crisp. A1Food food sells its product online. The company was founded in 2018 and is headquartered in Xiamen, Fujian.

Xiao Qu Hao Hushi provides online medical consultancy services through an application.

ZongMu Technology was founded in January 2013. Headquartered in Pudong ZhangJiang high-tech park of Shanghai, ZongMu has RD centers in Beijing and ShenZhen respectively. Through its innovative solution and excellent service to the local market, ZongMu has shipped multiple SurroundView ADAS (Advanced Driving Assistance System) in main stream OEM automotive markets, becoming the leading SurroundView ADAS solution vendor for China domestic market and formed strategic partnership with multiple OEM car makers and their tier1 suppliers.

Weijiecheng is a third-party city-based logistics service provider, providing the distribution of catering, retail, fresh e-commerce, fast-moving consumer goods and other consumer logistics markets with the “consultation + logistics service” model. Shanghai Kexin Logistics Co., Ltd. is a service brand.

Meet you is a female health management app that provides women's menstrual management consulting services. The app is providing mothers-to-be with rich pregnancy knowledge and intimate pregnancy reminders. Record the moment of baby growth and provide scientific advice on baby growth to mothers. At the same time, it provides girls with health, emotion, weight loss, beauty, and shopping knowledge posts, as well as a built-in real-girl communication area to accompany women during every important period.